BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deshpande A, Sicinski P, Hinds PW. Cyclins and cdks in development and cancer: a perspective. Oncogene. 2005;24:2909-2915. [PMID: 15838524 DOI: 10.1038/sj.onc.1208618] [Cited by in Crossref: 290] [Cited by in F6Publishing: 258] [Article Influence: 17.1] [Reference Citation Analysis]
Number Citing Articles
1 Fekry B, Ribas-Latre A, Drunen RV, Santos RB, Shivshankar S, Dai Y, Zhao Z, Yoo SH, Chen Z, Sun K, Sladek FM, Younes M, Eckel-Mahan K. Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis. FASEB J 2022;36:e22482. [PMID: 35947136 DOI: 10.1096/fj.202101398R] [Reference Citation Analysis]
2 Fu L, Mou J, Deng Y, Ren X, Qiu S. Design, Synthesis, and Activity Assays of Cyclin-Dependent Kinase 1 Inhibitors With Flavone Scaffolds. Front Chem 2022;10:940427. [DOI: 10.3389/fchem.2022.940427] [Reference Citation Analysis]
3 Ma L, Liu T, Lu Y, Dong Y, Zhao X, Man S. A natural halogenated fluoride adenosine analog 5'-fluorodeoxy adenosine induced anticolon cancer activity in vivo and in vitro. Environ Toxicol 2022. [PMID: 35866996 DOI: 10.1002/tox.23612] [Reference Citation Analysis]
4 El-sayed NNE, Zaki MEA, Al-hussain SA, Ben Bacha A, Berredjem M, Masand VH, Almarhoon ZM, Omar HS. Synthesis and Evaluation of Some New 4H-Pyran Derivatives as Antioxidant, Antibacterial and Anti-HCT-116 Cells of CRC, with Molecular Docking, Antiproliferative, Apoptotic and ADME Investigations. Pharmaceuticals 2022;15:891. [DOI: 10.3390/ph15070891] [Reference Citation Analysis]
5 Zabihi M, Lotfi R, Yousefi AM, Bashash D. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities. J Cancer Res Clin Oncol 2022. [PMID: 35781526 DOI: 10.1007/s00432-022-04135-6] [Reference Citation Analysis]
6 Naseer F, Ahmed M, Majid A, Kamal W, Phull AR. Green nanoparticles as multifunctional nanomedicines: Insights into anti-inflammatory effects, growth signaling and apoptosis mechanism in cancer. Semin Cancer Biol 2022:S1044-579X(22)00158-4. [PMID: 35787941 DOI: 10.1016/j.semcancer.2022.06.014] [Reference Citation Analysis]
7 Lv Y, Wang Y, Zhang Z, Bao J, Su H. Potentials of long non-coding RNAs as biomarkers of colorectal cancer. Clin Transl Oncol 2022. [PMID: 35581419 DOI: 10.1007/s12094-022-02834-7] [Reference Citation Analysis]
8 Dhingra M, Mahalanobis S, Das A. Thyroid receptor β might be responsible for breast cancer associated with Hashimoto's thyroiditis: a new insight into pathogenesis. Immunol Res 2022. [PMID: 35562625 DOI: 10.1007/s12026-022-09288-7] [Reference Citation Analysis]
9 Canário C, Matias M, Brito V, Pires P, Santos AO, Falcão A, Silvestre S, Alves G. C-Ring Oxidized Estrone Acetate Derivatives: Assessment of Antiproliferative Activities and Docking Studies. Applied Sciences 2022;12:3579. [DOI: 10.3390/app12073579] [Reference Citation Analysis]
10 Clark KL, George JW, Hua G, Davis JS. Perfluorooctanoic acid promotes proliferation of the human granulosa cell line HGrC1 and alters expression of cell cycle genes and Hippo pathway effector YAP1. Reprod Toxicol 2022:S0890-6238(22)00037-5. [PMID: 35346789 DOI: 10.1016/j.reprotox.2022.03.011] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang H, Man Q, Huo F, Gao X, Lin H, Li S, Wang J, Su F, Cai, L, Shi Y, Liu, B, Bu L. STAT3 pathway in cancers: Past, present, and future. MedComm 2022;3. [DOI: 10.1002/mco2.124] [Reference Citation Analysis]
12 Hendricks JA, Beaton N, Chernobrovkin A, Miele E, Hamza GM, Ricchiuto P, Tomlinson RC, Friman T, Borenstain C, Barlaam B, Hande S, Lamb ML, De Savi C, Davies R, Main M, Hellner J, Beeler K, Feng Y, Bruderer R, Reiter L, Molina DM, Castaldi MP. Mechanistic Insights into a CDK9 Inhibitor Via Orthogonal Proteomics Methods. ACS Chem Biol 2022;17:54-67. [PMID: 34955012 DOI: 10.1021/acschembio.1c00488] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 García-Osta A, Dong J, Moreno-Aliaga MJ, Ramirez MJ. p27, The Cell Cycle and Alzheimer´s Disease. Int J Mol Sci 2022;23:1211. [PMID: 35163135 DOI: 10.3390/ijms23031211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kahl I, Mense J, Finke C, Boller AL, Lorber C, Győrffy B, Greve B, Götte M, Espinoza-Sánchez NA. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients. J Cell Biochem 2022. [PMID: 35014077 DOI: 10.1002/jcb.30205] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Komarnicka UK, Pucelik B, Wojtala D, Lesiów MK, Stochel G, Kyzioł A. Evaluation of anticancer activity in vitro of a stable copper(I) complex with phosphine-peptide conjugate. Sci Rep 2021;11:23943. [PMID: 34907288 DOI: 10.1038/s41598-021-03352-2] [Reference Citation Analysis]
16 Islam R, Rahaman M, Hoque H, Hasan N, Prodhan SH, Ruhama A, Jewel NA. Computational and structural based approach to identify malignant nonsynonymous single nucleotide polymorphisms associated with CDK4 gene. PLoS One 2021;16:e0259691. [PMID: 34735543 DOI: 10.1371/journal.pone.0259691] [Reference Citation Analysis]
17 Wu ATH, Huang HS, Wen YT, Lawal B, Mokgautsi N, Huynh TT, Hsiao M, Wei L. A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling. Cells 2021;10:2391. [PMID: 34572040 DOI: 10.3390/cells10092391] [Reference Citation Analysis]
18 Ippati S, Deng Y, van der Hoven J, Heu C, van Hummel A, Chua SW, Paric E, Chan G, Feiten A, Fath T, Ke YD, Haass NK, Ittner LM. Rapid initiation of cell cycle reentry processes protects neurons from amyloid-β toxicity. Proc Natl Acad Sci U S A 2021;118:e2011876118. [PMID: 33737393 DOI: 10.1073/pnas.2011876118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Offermann A, Kang D, Watermann C, Weingart A, Hupe MC, Saraji A, Stegmann-Frehse J, Kruper R, Schüle R, Pantel K, Taubert H, Duensing S, Culig Z, Aigner A, Klapper W, Jonigk D, Philipp Kühnel M, Merseburger AS, Kirfel J, Sailer V, Perner S. Manuscript Title: Analysis of tripartite motif (TRIM) family gene expression in prostate cancer bone metastases. Carcinogenesis 2021:bgab083. [PMID: 34487169 DOI: 10.1093/carcin/bgab083] [Reference Citation Analysis]
20 Khan F, Pandey P, Jha NK, Khalid M, Ojha S. Rutin Mediated Apoptotic Cell Death in Caski Cervical Cancer Cells via Notch-1 and Hes-1 Downregulation. Life (Basel) 2021;11:761. [PMID: 34440505 DOI: 10.3390/life11080761] [Reference Citation Analysis]
21 Hu Y, Gao J, Wang M, Li M. Potential Prospect of CDK4/6 Inhibitors in Triple-Negative Breast Cancer. Cancer Manag Res 2021;13:5223-37. [PMID: 34234565 DOI: 10.2147/CMAR.S310649] [Reference Citation Analysis]
22 Westphal D, Garzarolli M, Sergon M, Horak P, Hutter B, Becker JC, Wiegel M, Maczey E, Blum S, Grosche-Schlee S, Rütten A, Ugurel S, Stenzinger A, Glimm H, Aust D, Baretton G, Beissert S, Fröhling S, Redler S, Surowy H, Meier F. High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma. Br J Dermatol 2021. [PMID: 34185311 DOI: 10.1111/bjd.20604] [Reference Citation Analysis]
23 Serra V, Orrù V, Steri M, Fiorillo E, Cucca F, Zoledziewska M. Genetic variant within CDK6 regulates immune response to palbociclib treatment. Clin Immunol 2021;:108777. [PMID: 34116212 DOI: 10.1016/j.clim.2021.108777] [Reference Citation Analysis]
24 Rajasekar N, Sivanantham A, Ravikumar V, Rajasekaran S. An overview on the role of plant-derived tannins for the treatment of lung cancer. Phytochemistry 2021;188:112799. [PMID: 33975161 DOI: 10.1016/j.phytochem.2021.112799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ou WB, Lundberg MZ, Zhu S, Bahri N, Kyriazoglou A, Xu L, Chen T, Mariño-Enriquez A, Fletcher JA. YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways. Oncogenesis 2021;10:37. [PMID: 33947829 DOI: 10.1038/s41389-021-00327-w] [Reference Citation Analysis]
26 Kashyap D, Garg VK, Sandberg EN, Goel N, Bishayee A. Oncogenic and Tumor Suppressive Components of the Cell Cycle in Breast Cancer Progression and Prognosis. Pharmaceutics 2021;13:569. [PMID: 33920506 DOI: 10.3390/pharmaceutics13040569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sarhan MO, Abd El-Karim SS, Anwar MM, Gouda RH, Zaghary WA, Khedr MA. Discovery of New Coumarin-Based Lead with Potential Anticancer, CDK4 Inhibition and Selective Radiotheranostic Effect: Synthesis, 2D & 3D QSAR, Molecular Dynamics, In Vitro Cytotoxicity, Radioiodination, and Biodistribution Studies. Molecules 2021;26:2273. [PMID: 33919867 DOI: 10.3390/molecules26082273] [Reference Citation Analysis]
28 Todorovic Z, Milovanovic J, Arsenijevic D, Vukovic N, Vukic M, Arsenijevic A, Djurdjevic P, Milovanovic M, Arsenijevic N. Shikonin Derivatives from Onsoma visianii Decrease Expression of Phosphorylated STAT3 in Leukemia Cells and Exert Antitumor Activity. Nutrients 2021;13:1147. [PMID: 33807148 DOI: 10.3390/nu13041147] [Reference Citation Analysis]
29 Efstathiou A, Smirlis D. Leishmania Protein Kinases: Important Regulators of the Parasite Life Cycle and Molecular Targets for Treating Leishmaniasis. Microorganisms 2021;9:691. [PMID: 33801655 DOI: 10.3390/microorganisms9040691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Calaf GM, Bleak TC, Roy D. Signs of carcinogenicity induced by parathion, malathion, and estrogen in human breast epithelial cells (Review). Oncol Rep 2021;45:24. [PMID: 33649804 DOI: 10.3892/or.2021.7975] [Reference Citation Analysis]
31 Fouad S, Hauton D, D'Angiolella V. E2F1: Cause and Consequence of DNA Replication Stress. Front Mol Biosci 2020;7:599332. [PMID: 33665206 DOI: 10.3389/fmolb.2020.599332] [Reference Citation Analysis]
32 Cao Y, Zhang Y, Ma L, Wang J, Guo W, Cheng J, Hu G, Fu S, Liu J. Niacin stimulates EPH4EV mammary epithelial cell proliferation and mammary gland development in pubertal mice through activation of AKT/mTOR and ERK1/2 signaling pathways. Cell Tissue Res 2021;384:313-24. [PMID: 33576879 DOI: 10.1007/s00441-020-03355-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Li Y, Du R, Nie Y, Wang T, Ma Y, Fan Y. Design, synthesis and biological assessment of novel CDK4 inhibitor with potent anticancer activity. Bioorg Chem 2021;109:104717. [PMID: 33647744 DOI: 10.1016/j.bioorg.2021.104717] [Reference Citation Analysis]
34 Liu W, Yi JM, Liu Y, Chen C, Zhang KX, Zhou C, Zhan HE, Zhao L, Morales S, Zhao XL, Zeng H. CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia. Front Genet 2020;11:600227. [PMID: 33597968 DOI: 10.3389/fgene.2020.600227] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Roupakia E, Markopoulos GS, Kolettas E. Genes and pathways involved in senescence bypass identified by functional genetic screens. Mech Ageing Dev 2021;194:111432. [PMID: 33422562 DOI: 10.1016/j.mad.2021.111432] [Reference Citation Analysis]
36 Park SY, Kim KY, Jun DY, Hwang SK, Kim YH. G1 Cell Cycle Arrest and Extrinsic Apoptotic Mechanisms Underlying the Anti-Leukemic Activity of CDK7 Inhibitor BS-181. Cancers (Basel) 2020;12:E3845. [PMID: 33352782 DOI: 10.3390/cancers12123845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Hu HT, Wang Z, Kim MJ, Jiang LS, Xu SJ, Jung J, Lee E, Park JH, Bakheet N, Yoon SH, Kim KY, Song HY, Chang S. The Establishment of a Fast and Safe Orthotopic Colon Cancer Model Using a Tissue Adhesive Technique. Cancer Res Treat 2021;53:733-43. [PMID: 33321564 DOI: 10.4143/crt.2020.494] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Auler M, Bergmeier V, Georgieva VS, Pitzler L, Frie C, Nüchel J, Eckes B, Hinz B, Brachvogel B. miR-127-3p Is an Epigenetic Activator of Myofibroblast Senescence Situated within the MicroRNA-Enriched Dlk1-Dio3‒Imprinted Domain on Mouse Chromosome 12. J Invest Dermatol 2021;141:1076-1086.e3. [PMID: 33279585 DOI: 10.1016/j.jid.2020.11.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Rahman Z, Bazaz MR, Devabattula G, Khan MA, Godugu C. Targeting H3K9 methyltransferase G9a and its related molecule GLP as a potential therapeutic strategy for cancer. J Biochem Mol Toxicol 2021;35:e22674. [PMID: 33283949 DOI: 10.1002/jbt.22674] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Mou J, Chen D, Deng Y. Inhibitors of Cyclin-Dependent Kinase 1/2 for Anticancer Treatment. Med Chem 2020;16:307-25. [PMID: 31241436 DOI: 10.2174/1573406415666190626113900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Sviderskiy VO, Blumenberg L, Gorodetsky E, Karakousi TR, Hirsh N, Alvarez SW, Terzi EM, Kaparos E, Whiten GC, Ssebyala S, Tonzi P, Mir H, Neel BG, Huang TT, Adams S, Ruggles KV, Possemato R. Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that Can Be Exploited by Targeting DNA Polymerase ε. Mol Cell 2020;80:682-698.e7. [PMID: 33152268 DOI: 10.1016/j.molcel.2020.10.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
42 Golrokh Mofrad M, Taghizadeh Maleki D, Faghihloo E. The roles of programmed death ligand 1 in virus-associated cancers. Infection, Genetics and Evolution 2020;84:104368. [DOI: 10.1016/j.meegid.2020.104368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
43 Marak BN, Dowarah J, Khiangte L, Singh VP. A comprehensive insight on the recent development of Cyclic Dependent Kinase inhibitors as anticancer agents. European Journal of Medicinal Chemistry 2020;203:112571. [DOI: 10.1016/j.ejmech.2020.112571] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
44 Pei Y, Wong JHY, Robertson ES. Targeted Therapies for Epstein-Barr Virus-Associated Lymphomas. Cancers (Basel) 2020;12:E2565. [PMID: 32916819 DOI: 10.3390/cancers12092565] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
45 Wang H, Lin SY, Hu FF, Guo AY, Hu H. The expression and regulation of HOX genes and membrane proteins among different cytogenetic groups of acute myeloid leukemia. Mol Genet Genomic Med 2020;8:e1365. [PMID: 32614525 DOI: 10.1002/mgg3.1365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Gong T, Li Y, Feng L, Fang M, Dai G, Huang X, Yang Y, Liu S. CASC21, a FOXP1 induced long non-coding RNA, promotes colorectal cancer growth by regulating CDK6. Aging (Albany NY) 2020;12:12086-106. [PMID: 32584787 DOI: 10.18632/aging.103376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
47 Fassl A, Brain C, Abu-Remaileh M, Stukan I, Butter D, Stepien P, Feit AS, Bergholz J, Michowski W, Otto T, Sheng Q, Loo A, Michael W, Tiedt R, DeAngelis C, Schiff R, Jiang B, Jovanovic B, Nowak K, Ericsson M, Cameron M, Gray N, Dillon D, Zhao JJ, Sabatini DM, Jeselsohn R, Brown M, Polyak K, Sicinski P. Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition. Sci Adv 2020;6:eabb2210. [PMID: 32704543 DOI: 10.1126/sciadv.abb2210] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
48 Kulka LAM, Fangmann PV, Panfilova D, Olzscha H. Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease. Front Cell Dev Biol 2020;8:425. [PMID: 32582706 DOI: 10.3389/fcell.2020.00425] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
49 Benazic S, Silconi ZB, Jevtovic A, Jurisevic M, Milovanovic J, Mijajlovic M, Nikolic M, Kanjevac T, Potočňák I, Samoľová E, Ratkovic ZR, Radic G, Milovanovic M, Pantic J, Arsenijevic N, Radosavljevic GD. The Zn(S-pr-thiosal)2 complex attenuates murine breast cancer growth by inducing apoptosis and G1/S cell cycle arrest. Future Med Chem 2020;12:897-914. [PMID: 32267176 DOI: 10.4155/fmc-2019-0215] [Reference Citation Analysis]
50 Gao X, Leone GW, Wang H. Cyclin D-CDK4/6 functions in cancer. Adv Cancer Res 2020;148:147-69. [PMID: 32723562 DOI: 10.1016/bs.acr.2020.02.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
51 Wu Y, Tang W, Cao Y, Jiang D, Zhao L, Zhao J, Zhang Y, Li C, Cheng C, Wang S, Yang F, Zhu X, Li G. A Cyclin D1-Specific Single-Chain Variable Fragment Antibody that Inhibits HepG2 Cell Growth and Proliferation. Biotechnol J 2020;15:e1900430. [PMID: 32170989 DOI: 10.1002/biot.201900430] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Novotný J, Bandúrová V, Strnad H, Chovanec M, Hradilová M, Šáchová J, Šteffl M, Grušanović J, Kodet R, Pačes V, Lacina L, Smetana K Jr., Plzák J, Kolář M, Vomastek T. Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas and Paired Normal Mucosae Reveals Cyclin D1 Deregulation and Compensatory Effect of Cyclin D2. Cancers (Basel) 2020;12:E792. [PMID: 32224897 DOI: 10.3390/cancers12040792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Wallmann A, Kesten C. Common Functions of Disordered Proteins across Evolutionary Distant Organisms. Int J Mol Sci 2020;21:E2105. [PMID: 32204351 DOI: 10.3390/ijms21062105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
54 Wang X, Deng K, Wang C, Li Y, Wang T, Huang Z, Ma Y, Sun P, Shi Y, Yang S, Fan Y, Xiang R. Novel CDKs inhibitors for the treatment of solid tumour by simultaneously regulating the cell cycle and transcription control. J Enzyme Inhib Med Chem 2020;35:414-23. [PMID: 31899991 DOI: 10.1080/14756366.2019.1705290] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
55 Wang Y, Chen X, Yan Y, Zhu X, Liu M, Liu X. Discovery and SARs of 5-Chloro- N4 -phenyl- N2 -(pyridin-2-yl)pyrimidine-2,4-diamine Derivatives as Oral Available and Dual CDK 6 and 9 Inhibitors with Potent Antitumor Activity. J Med Chem 2020;63:3327-47. [DOI: 10.1021/acs.jmedchem.9b02121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
56 Xin ZH, Meng YL, Jiang WJ, Li YP, Ge LP, Zhang CH, Liu LN, Kang YF. Finding an efficient tetramethylated hydroxydiethylene of resveratrol analogue for potential anticancer agent. BMC Chem 2020;14:13. [PMID: 32099972 DOI: 10.1186/s13065-020-00667-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Kumar R, Awasthi M, Sharma A, Padwad Y, Sharma R. Berberine induces dose-dependent quiescence and apoptosis in A549 cancer cells by modulating cell cyclins and inflammation independent of mTOR pathway. Life Sci 2020;244:117346. [PMID: 31978448 DOI: 10.1016/j.lfs.2020.117346] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
58 Lu P, Cai X, Guo Y, Xu M, Tian J, Locker J, Xie W. Constitutive Activation of the Human Aryl Hydrocarbon Receptor in Mice Promotes Hepatocarcinogenesis Independent of Its Coactivator Gadd45b. Toxicol Sci 2019;167:581-92. [PMID: 30346592 DOI: 10.1093/toxsci/kfy263] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
59 Liu D, Zhou G, Shi H, Chen B, Sun X, Zhang X. Downregulation of Transmembrane protein 40 by miR-138-5p Suppresses Cell Proliferation and Mobility in Clear Cell Renal Cell Carcinoma. Iran J Biotechnol 2020;18:e2270. [PMID: 32884956 DOI: 10.30498/IJB.2019.85193] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Li Y, Wang G, Liu J, Ouyang L. Quinolizidine alkaloids derivatives from Sophora alopecuroides Linn: Bioactivities, structure-activity relationships and preliminary molecular mechanisms. Eur J Med Chem 2020;188:111972. [PMID: 31884408 DOI: 10.1016/j.ejmech.2019.111972] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
61 Jiménez-Vacas JM, Gómez-Gómez E, Montero-Hidalgo AJ, Herrero-Aguayo V, L-López F, Sánchez-Sánchez R, Guler I, Blanca A, Méndez-Vidal MJ, Carrasco J, Lopez-Miranda J, Requena-Tapia MJ, Castaño JP, Gahete MD, Luque RM. Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer. J Clin Med 2019;8:E2056. [PMID: 31766715 DOI: 10.3390/jcm8122056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
62 Zhao B, Luo J, Wang Y, Zhou L, Che J, Wang F, Peng S, Zhang G, Shang P. Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy. Oxid Med Cell Longev. 2019;2019:9290728. [PMID: 31827709 DOI: 10.1155/2019/9290728] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
63 Boudreau MW, Peh J, Hergenrother PJ. Procaspase-3 Overexpression in Cancer: A Paradoxical Observation with Therapeutic Potential. ACS Chem Biol 2019;14:2335-48. [PMID: 31260254 DOI: 10.1021/acschembio.9b00338] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
64 Gu J, Zhang X, Yang Z, Wang N. Expression Of Cyclin D1 Protein Isoforms And Its Prognostic Significance In Cervical Cancer. Cancer Manag Res 2019;11:9073-83. [PMID: 31695498 DOI: 10.2147/CMAR.S224026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Kim D, Wang CY, Hu R, Lee JY, Luu T, Park H, Lee SK. Antitumor Activity of Vanicoside B Isolated from Persicaria dissitiflora by Targeting CDK8 in Triple-Negative Breast Cancer Cells. J Nat Prod 2019;82:3140-9. [DOI: 10.1021/acs.jnatprod.9b00720] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
66 Bansode P, Anantacharya R, Dhanavade M, Kamble S, Barale S, Sonawane K, Satyanarayan ND, Rashinkar G. Evaluation of drug candidature: In silico ADMET, binding interactions with CDK7 and normal cell line studies of potentially anti-breast cancer enamidines. Comput Biol Chem 2019;83:107124. [PMID: 31563021 DOI: 10.1016/j.compbiolchem.2019.107124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 González-Arenas A, De la Fuente-Granada M, Camacho-Arroyo I, Zamora-Sánchez CJ, Piña-Medina AG, Segura-Uribe J, Guerra-Araiza C. Tibolone Effects on Human Glioblastoma Cell Lines. Arch Med Res 2019;50:187-96. [PMID: 31499479 DOI: 10.1016/j.arcmed.2019.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
68 Niu Y, Xu J, Sun T. Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: Current Status, Resistance, and Combination Strategies. J Cancer 2019;10:5504-17. [PMID: 31632494 DOI: 10.7150/jca.32628] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
69 Kang H, Heo S, Shin JJ, Ji E, Tak H, Ahn S, Lee KJ, Lee EK, Kim W. A miR‐194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinoma. J Pathol 2019;249:395-408. [DOI: 10.1002/path.5325] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
70 Yao DW, Balanis NG, Eskin E, Graeber TG. A linear mixed model approach to gene expression-tumor aneuploidy association studies. Sci Rep 2019;9:11944. [PMID: 31420589 DOI: 10.1038/s41598-019-48302-1] [Reference Citation Analysis]
71 Martínez-Carreres L, Puyal J, Leal-Esteban LC, Orpinell M, Castillo-Armengol J, Giralt A, Dergai O, Moret C, Barquissau V, Nasrallah A, Pabois A, Zhang L, Romero P, Lopez-Mejia IC, Fajas L. CDK4 Regulates Lysosomal Function and mTORC1 Activation to Promote Cancer Cell Survival. Cancer Res 2019;79:5245-59. [PMID: 31395606 DOI: 10.1158/0008-5472.CAN-19-0708] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
72 Huang Z, Zhao B, Qin Z, Li Y, Wang T, Zhou W, Zheng J, Yang S, Shi Y, Fan Y, Xiang R. Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis. Eur J Med Chem 2019;181:111541. [PMID: 31382120 DOI: 10.1016/j.ejmech.2019.07.044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
73 Sharma N, Anurag. 7-Azaindole Analogues as Bioactive Agents and Recent Results. Mini Rev Med Chem 2019;19:727-36. [PMID: 30264679 DOI: 10.2174/1389557518666180928154004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
74 Zhao Y, Yu Y, Zhao W, You S, Feng M, Xie C, Chi X, Zhang Y, Wang X. As a downstream target of the AKT pathway, NPTX1 inhibits proliferation and promotes apoptosis in hepatocellular carcinoma. Biosci Rep 2019;39:BSR20181662. [PMID: 31113871 DOI: 10.1042/BSR20181662] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
75 Karna SKL, Ahmad F, Lone BA, Pokharel YR. Knockdown of PTOV1 and PIN1 exhibit common phenotypic anti-cancer effects in MDA-MB-231 cells. PLoS One 2019;14:e0211658. [PMID: 31083670 DOI: 10.1371/journal.pone.0211658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Ding ZY, Li R, Zhang QJ, Wang Y, Jiang Y, Meng QY, Xi QL, Wu GH. Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta-analysis. Cancer Med 2019;8:2717-29. [PMID: 30950241 DOI: 10.1002/cam4.2152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
77 Yang Y, Zhang K, Chen L, Li L. The combination of four cell-cycle regulators: a new direction for inducing adult cardiomyocyte proliferation. Acta Biochim Biophys Sin (Shanghai) 2019;51:452-4. [PMID: 30824904 DOI: 10.1093/abbs/gmz012] [Reference Citation Analysis]
78 Lokhande KB, Nagar S, Swamy KV. Molecular interaction studies of Deguelin and its derivatives with Cyclin D1 and Cyclin E in cancer cell signaling pathway: The computational approach. Sci Rep 2019;9:1778. [PMID: 30741976 DOI: 10.1038/s41598-018-38332-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
79 Thwaites MJ, Cecchini MJ, Passos DT, Zakirova K, Dick FA. Context dependent roles for RB-E2F transcriptional regulation in tumor suppression. PLoS One 2019;14:e0203577. [PMID: 30703085 DOI: 10.1371/journal.pone.0203577] [Reference Citation Analysis]
80 Dey P, Kundu A, Chakraborty HJ, Kar B, Choi WS, Lee BM, Bhakta T, Atanasov AG, Kim HS. Therapeutic value of steroidal alkaloids in cancer: Current trends and future perspectives. Int J Cancer 2019;145:1731-44. [PMID: 30387881 DOI: 10.1002/ijc.31965] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 7.3] [Reference Citation Analysis]
81 Zou X, Hu J, Wang M, Du Y, Li J, Mai Q, Deng Z. [1–9-NαC]-linusorb B2 and [1–9-NαC]-linusorb B3 isolated from flaxseed induce G1 cell cycle arrest on SGC-7901 cells by modulating the AKT/JNK signaling pathway. Journal of Functional Foods 2019;52:332-9. [DOI: 10.1016/j.jff.2018.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
82 Khanapure S, Jagadale M, Bansode P, Choudhari P, Rashinkar G. Anticancer activity of ruthenocenyl chalcones and their molecular docking studies. Journal of Molecular Structure 2018;1173:142-7. [DOI: 10.1016/j.molstruc.2018.06.091] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
83 Altawaty T, Liu L, Zhang H, Tao C, Hou S, Li K, Wang Y. Lack of LTβR Increases Susceptibility of IPEC-J2 Cells to Porcine Epidemic Diarrhea Virus. Cells 2018;7:E222. [PMID: 30469426 DOI: 10.3390/cells7110222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
84 Pandey V, Zhang M, You M, Zhang W, Chen R, Zhang W, Ma L, Wu ZS, Zhu T, Xu XQ, Lobie PE. Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells. Cell Death Dis 2018;9:1147. [PMID: 30451834 DOI: 10.1038/s41419-018-1177-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
85 Gao X, Cen L, Li F, Wen R, Yan H, Yao H, Zhu S. Oral administration of indole substituted dipyrido[2,3-d]pyrimidine derivative exhibits anti-tumor activity via inhibiting AKT and ERK1/2 on hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2018;505:761-7. [DOI: 10.1016/j.bbrc.2018.09.120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
86 Xu M, Chen X, Lin K, Zeng K, Liu X, Pan B, Xu X, Xu T, Hu X, Sun L, He B, Pan Y, Sun H, Wang S. The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p. Mol Cancer 2018;17:141. [PMID: 30266084 DOI: 10.1186/s12943-018-0894-x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 116] [Article Influence: 28.0] [Reference Citation Analysis]
87 Caruso JA, Duong MT, Carey JPW, Hunt KK, Keyomarsi K. Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies. Cancer Res 2018;78:5481-91. [PMID: 30194068 DOI: 10.1158/0008-5472.CAN-18-1235] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
88 Nilubol N, Boufraqech M, Zhang L, Gaskins K, Shen M, Zhang YQ, Gara SK, Austin CP, Kebebew E. Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response. Oncotarget 2018;9:33030-42. [PMID: 30250647 DOI: 10.18632/oncotarget.26050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
89 Chohan TA, Qayyum A, Rehman K, Tariq M, Akash MSH. An insight into the emerging role of cyclin-dependent kinase inhibitors as potential therapeutic agents for the treatment of advanced cancers. Biomed Pharmacother 2018;107:1326-41. [PMID: 30257348 DOI: 10.1016/j.biopha.2018.08.116] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
90 Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ. Activity of roniciclib in medullary thyroid cancer. Oncotarget 2018;9:28030-41. [PMID: 29963260 DOI: 10.18632/oncotarget.25555] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
91 Jurisevic M, Arsenijevic A, Pantic J, Gajovic N, Milovanovic J, Milovanovic M, Poljarevic J, Sabo T, Vojvodic D, Radosavljevic GD, Arsenijevic N. The organic ester O,O'-diethyl-(S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoate dihydrochloride attenuates murine breast cancer growth and metastasis. Oncotarget 2018;9:28195-212. [PMID: 29963272 DOI: 10.18632/oncotarget.25610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Gordon EM, Ravicz JR, Liu S, Chawla SP, Hall FL. Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad-spectrum cancer gene therapy - A review of molecular mechanisms for oncologists. Mol Clin Oncol 2018;9:115-34. [PMID: 30101008 DOI: 10.3892/mco.2018.1657] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
93 Liu D, You P, Luo Y, Yang M, Liu Y. Galangin Induces Apoptosis in MCF-7 Human Breast Cancer Cells Through Mitochondrial Pathway and Phosphatidylinositol 3-Kinase/Akt Inhibition. Pharmacology 2018;102:58-66. [PMID: 29879712 DOI: 10.1159/000489564] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
94 Jing L, Tang Y, Xiao Z. Discovery of novel CDK inhibitors via scaffold hopping from CAN508. Bioorganic & Medicinal Chemistry Letters 2018;28:1386-91. [DOI: 10.1016/j.bmcl.2018.02.054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
95 Zeng R, Liu Y, Jiang ZJ, Huang JP, Wang Y, Li XF, Xiong WB, Wu XC, Zhang JR, Wang QE, Zheng YF. EPB41L3 is a potential tumor suppressor gene and prognostic indicator in esophageal squamous cell carcinoma. Int J Oncol 2018;52:1443-54. [PMID: 29568917 DOI: 10.3892/ijo.2018.4316] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
96 Rampogu S, Baek A, Zeb A, Lee KW. Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations. BMC Cancer 2018;18:264. [PMID: 29514608 DOI: 10.1186/s12885-018-4050-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
97 Peng X, Pan K, Zhao W, Zhang J, Yuan S, Wen X, Zhou W, Yu Z. NPTX1 inhibits colon cancer cell proliferation through down-regulating cyclin A2 and CDK2 expression: Down-regulation of NPTX1 in colon cancer. Cell Biol Int 2018;42:589-97. [DOI: 10.1002/cbin.10935] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
98 Mi Y, Zhao S, Zhou C, Weng J, Li J, Wang Z, Sun H, Tang H, Zhang X, Sun X, Peng Z, Wen Y. Downregulation of homeobox gene Barx2 increases gastric cancer proliferation and metastasis and predicts poor patient outcomes. Oncotarget 2016;7:60593-608. [PMID: 27533254 DOI: 10.18632/oncotarget.11260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
99 Gu W, Mochizuki K, Otsuka K, Hamada R, Takehara A, Matsui Y. Dnd1-mediated epigenetic control of teratoma formation in mouse. Biol Open 2018;7:bio032318. [PMID: 29378702 DOI: 10.1242/bio.032318] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
100 Zhang J, Liu L, Sun Y, Xiang J, Zhou D, Wang L, Xu H, Yang X, Du N, Zhang M, Yan Q, Xi X. MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression. Oncotarget 2016;7:26516-34. [PMID: 27049921 DOI: 10.18632/oncotarget.8530] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
101 Zhao S, Tang H, Yan D, Fan J, Sun H, Wen Y, Yu F, Cui F, Zhang D, Xue Y, Liu C, Yue B, Chen J, Wang J, Wang X, Zhang M, Yu Y, Jiang W, Liu X, Mi Y, Zhou Z, Qin X, Peng Z. DDA1 promotes stage IIB-IIC colon cancer progression by activating NFκB/CSN2/GSK-3β signaling. Oncotarget 2016;7:19794-812. [PMID: 26942699 DOI: 10.18632/oncotarget.7847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
102 Zhang HP, Wang YH, Ma SC, Zhang H, Yang AN, Yang XL, Zhang MH, Sun JM, Hao YJ, Jiang YD. Homocysteine inhibits endothelial progenitor cells proliferation via DNMT1-mediated hypomethylation of Cyclin A. Exp Cell Res 2018;362:217-26. [PMID: 29155363 DOI: 10.1016/j.yexcr.2017.11.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
103 Hydbring P, Wang Y, Bogorad RL, Yin H, Anderson DG, Li C, Sicinski P. Identification of cell cycle-targeting microRNAs through genome-wide screens. Cell Cycle 2017;16:2241-8. [PMID: 29099267 DOI: 10.1080/15384101.2017.1380132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
104 Liu H, Yue Q, He S. Amentoflavone suppresses tumor growth in ovarian cancer by modulating Skp2. Life Sciences 2017;189:96-105. [DOI: 10.1016/j.lfs.2017.09.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
105 Calcabrini C, Catanzaro E, Bishayee A, Turrini E, Fimognari C. Marine Sponge Natural Products with Anticancer Potential: An Updated Review. Mar Drugs 2017;15:E310. [PMID: 29027954 DOI: 10.3390/md15100310] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 11.8] [Reference Citation Analysis]
106 Moody C. Mechanisms by which HPV Induces a Replication Competent Environment in Differentiating Keratinocytes. Viruses 2017;9:E261. [PMID: 28925973 DOI: 10.3390/v9090261] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
107 Chen QY, Costa M. A comprehensive review of metal-induced cellular transformation studies. Toxicology and Applied Pharmacology 2017;331:33-40. [DOI: 10.1016/j.taap.2017.05.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
108 Gouda AM, Abdelazeem AH, Omar HA, Abdalla AN, Abourehab MAS, Ali HI. Pyrrolizines: Design, synthesis, anticancer evaluation and investigation of the potential mechanism of action. Bioorg Med Chem 2017;25:5637-51. [PMID: 28916158 DOI: 10.1016/j.bmc.2017.08.039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
109 Sun X, Zhong Y, Luo H, Yang Y. Selenium-Containing Polysaccharide-Protein Complex in Se-Enriched Ulva fasciata Induces Mitochondria-Mediated Apoptosis in A549 Human Lung Cancer Cells. Mar Drugs 2017;15:E215. [PMID: 28714901 DOI: 10.3390/md15070215] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
110 Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ. Effects of roniciclib in preclinical models of anaplastic thyroid cancer. Oncotarget 2017;8:67990-8000. [PMID: 28978090 DOI: 10.18632/oncotarget.19092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
111 Khanna V, Eide CA, Tognon CE, Maxson JE, Wilmot B, Bottomly D, McWeeney S, Edwards V DK, Druker BJ, Tyner JW. Recurrent cyclin D2 mutations in myeloid neoplasms. Leukemia 2017;31:2005-8. [PMID: 28630439 DOI: 10.1038/leu.2017.195] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
112 Wang H, Nicolay BN, Chick JM, Gao X, Geng Y, Ren H, Gao H, Yang G, Williams JA, Suski JM, Keibler MA, Sicinska E, Gerdemann U, Haining WN, Roberts TM, Polyak K, Gygi SP, Dyson NJ, Sicinski P. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Nature 2017;546:426-30. [PMID: 28607489 DOI: 10.1038/nature22797] [Cited by in Crossref: 164] [Cited by in F6Publishing: 156] [Article Influence: 32.8] [Reference Citation Analysis]
113 Krall AS, Christofk HR. Cell cycle: Division enzyme regulates metabolism. Nature 2017;546:357-8. [PMID: 28607481 DOI: 10.1038/nature22504] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
114 Lu S, Ahmed T, Du P, Wang Y. Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment. Int J Mol Sci 2017;18:E1201. [PMID: 28587243 DOI: 10.3390/ijms18061201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
115 Peng Y, Scott P, Tao R, Wang H, Wu Y, Peng G. Dissect the Dynamic Molecular Circuits of Cell Cycle Control through Network Evolution Model. Biomed Res Int 2017;2017:2954351. [PMID: 28466007 DOI: 10.1155/2017/2954351] [Reference Citation Analysis]
116 Ding L, Ni J, Yang F, Huang L, Deng H, Wu Y, Ding X, Tang J. Promising therapeutic role of miR-27b in tumor. Tumour Biol 2017;39:1010428317691657. [PMID: 28351320 DOI: 10.1177/1010428317691657] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
117 Mittal S, Banks L. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation. Mutation Research/Reviews in Mutation Research 2017;772:23-35. [DOI: 10.1016/j.mrrev.2016.08.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 13.2] [Reference Citation Analysis]
118 Giráldez S, Galindo-Moreno M, Limón-Mortés MC, Rivas AC, Herrero-Ruiz J, Mora-Santos M, Sáez C, Japón MÁ, Tortolero M, Romero F. G1/S phase progression is regulated by PLK1 degradation through the CDK1/βTrCP axis. FASEB J 2017;31:2925-36. [PMID: 28360195 DOI: 10.1096/fj.201601108R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
119 Tao YF, Wang NN, Xu LX, Li ZH, Li XL, Xu YY, Fang F, Li M, Qian GH, Li YH, Li YP, Wu Y, Ren JL, Du WW, Lu J, Feng X, Wang J, He WQ, Hu SY, Pan J. Molecular mechanism of G1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells. Cancer Cell Int 2017;17:35. [PMID: 28286417 DOI: 10.1186/s12935-017-0405-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
120 Zhang F, Shi JJ, Thakur K, Hu F, Zhang JG, Wei ZJ. Anti-Cancerous Potential of Polysaccharide Fractions Extracted from Peony Seed Dreg on Various Human Cancer Cell Lines Via Cell Cycle Arrest and Apoptosis. Front Pharmacol 2017;8:102. [PMID: 28316571 DOI: 10.3389/fphar.2017.00102] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
121 Cheng L, Yang Q, Li C, Dai L, Yang Y, Wang Q, Ding Y, Zhang J, Liu L, Zhang S, Fan P, Hu X, Xiang R, Yu D, Wei Y, Deng H. DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle. J Cell Mol Med 2017;21:1532-44. [PMID: 28211159 DOI: 10.1111/jcmm.13084] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
122 Garrido-Castro AC, Goel S. CDK4/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment Failure. Curr Breast Cancer Rep 2017;9:26-33. [PMID: 28479958 DOI: 10.1007/s12609-017-0232-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
123 Thwaites MJ, Cecchini MJ, Passos DT, Welch I, Dick FA. Interchangeable Roles for E2F Transcriptional Repression by the Retinoblastoma Protein and p27KIP1-Cyclin-Dependent Kinase Regulation in Cell Cycle Control and Tumor Suppression. Mol Cell Biol 2017;37:e00561-16. [PMID: 27821477 DOI: 10.1128/MCB.00561-16] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
124 Gao X, Jiang Y, Han L, Chen X, Hu C, Su H, Mu Y, Guan P, Huang X. Effect of borrelidin on hepatocellular carcinoma cells in vitro and in vivo. RSC Adv 2017;7:44401-9. [DOI: 10.1039/c7ra08290h] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
125 Wen L, Guo R, You L, Abbasi AM, Li T, Fu X, Liu RH. Major triterpenoids in Chinese hawthorn "Crataegus pinnatifida" and their effects on cell proliferation and apoptosis induction in MDA-MB-231 cancer cells. Food Chem Toxicol 2017;100:149-60. [PMID: 28025124 DOI: 10.1016/j.fct.2016.12.032] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
126 Vella S, Tavanti E, Hattinger CM, Fanelli M, Versteeg R, Koster J, Picci P, Serra M. Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells. PLoS One 2016;11:e0166233. [PMID: 27898692 DOI: 10.1371/journal.pone.0166233] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
127 Eisfeld AK, Kohlschmidt J, Schwind S, Nicolet D, Blachly JS, Orwick S, Shah C, Bainazar M, Kroll KW, Walker CJ, Carroll AJ, Powell BL, Stone RM, Kolitz JE, Baer MR, de la Chapelle A, Mrózek K, Byrd JC, Bloomfield CD. Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia. Leukemia 2017;31:1278-85. [PMID: 27843138 DOI: 10.1038/leu.2016.332] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
128 Banerjee J, Pradhan R, Gupta A, Kumar R, Sahu V, Upadhyay AD, Chaterjee P, Dwivedi S, Dey S, Dey AB. CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker. Clin Transl Oncol 2017;19:571-8. [PMID: 27815686 DOI: 10.1007/s12094-016-1565-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
129 Minarikova P, Benesova L, Halkova T, Belsanova B, Tuckova I, Belina F, Dusek L, Zavoral M, Minarik M. Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers. Gastroenterol Res Pract 2016;2016:9408190. [PMID: 27781065 DOI: 10.1155/2016/9408190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
130 Goto H, Inaba H, Inagaki M. Mechanisms of ciliogenesis suppression in dividing cells. Cell Mol Life Sci 2017;74:881-90. [PMID: 27669693 DOI: 10.1007/s00018-016-2369-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
131 Nomanbhoy TK, Sharma G, Brown H, Wu J, Aban A, Vogeti S, Alemayehu S, Sykes M, Rosenblum JS, Kozarich JW. Chemoproteomic Evaluation of Target Engagement by the Cyclin-Dependent Kinase 4 and 6 Inhibitor Palbociclib Correlates with Cancer Cell Response. Biochemistry 2016;55:5434-41. [PMID: 27571378 DOI: 10.1021/acs.biochem.6b00629] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
132 Tadesse S, Yu M, Kumarasiri M, Le BT, Wang S. Targeting CDK6 in cancer: State of the art and new insights. Cell Cycle 2015;14:3220-30. [PMID: 26315616 DOI: 10.1080/15384101.2015.1084445] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 9.3] [Reference Citation Analysis]
133 Jagadish N, Gupta N, Agarwal S, Parashar D, Sharma A, Fatima R, Topno AP, Kumar V, Suri A. Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells. Tumour Biol 2016;37:13101-10. [PMID: 27449044 DOI: 10.1007/s13277-016-5240-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
134 Huth HW, Albarnaz JD, Torres AA, Bonjardim CA, Ropert C. MEK2 controls the activation of MKK3/MKK6-p38 axis involved in the MDA-MB-231 breast cancer cell survival: Correlation with cyclin D1 expression. Cell Signal 2016;28:1283-91. [PMID: 27181679 DOI: 10.1016/j.cellsig.2016.05.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
135 Hydbring P, Malumbres M, Sicinski P. Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases. Nat Rev Mol Cell Biol. 2016;17:280-292. [PMID: 27033256 DOI: 10.1038/nrm.2016.27] [Cited by in Crossref: 229] [Cited by in F6Publishing: 224] [Article Influence: 38.2] [Reference Citation Analysis]
136 Lanza DG, Dawson EP, Rao P, Heaney JD. Misexpression of cyclin D1 in embryonic germ cells promotes testicular teratoma initiation. Cell Cycle 2016;15:919-30. [PMID: 26901436 DOI: 10.1080/15384101.2016.1149272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
137 Balakrishnan A, Vyas A, Deshpande K, Vyas D. Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer. World J Gastroenterol 2016; 22(7): 2159-2164 [PMID: 26900281 DOI: 10.3748/wjg.v22.i7.2159] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
138 Oliveira ACN, Nogueira SS, Gonçalves O, Cerqueira MF, Alpuim P, Tovar J, Rodriguez-abreu C, Brezesinski G, Gomes AC, Lúcio M, Oliveira MECDR. Role of counter-ion and helper lipid content in the design and properties of nanocarrier systems: a biophysical study in 2D and 3D lipid assemblies. RSC Adv 2016;6:47730-40. [DOI: 10.1039/c6ra08125h] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
139 Chen L, Lv D, Wang D, Chen X, Zhu Z, Cao Y, Chai Y. A novel strategy of profiling the mechanism of herbal medicines by combining network pharmacology with plasma concentration determination and affinity constant measurement. Mol BioSyst 2016;12:3347-56. [DOI: 10.1039/c6mb00500d] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
140 Baltus CB, Jorda R, Marot C, Berka K, Bazgier V, Kryštof V, Prié G, Viaud-massuard M. Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors. European Journal of Medicinal Chemistry 2016;108:701-19. [DOI: 10.1016/j.ejmech.2015.12.023] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
141 Dachineni R, Ai G, Kumar DR, Sadhu SS, Tummala H, Bhat GJ. Cyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer Prevention. Mol Cancer Res 2016;14:241-52. [PMID: 26685215 DOI: 10.1158/1541-7786.MCR-15-0360] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
142 Sato-Kuwabara Y, Fregnani JH, Jampietro J, Carvalho KC, Franco CP, da Costa WL Jr, Coimbra FJ, Soares FA. Comparative analysis of basaloid and conventional squamous cell carcinomas of the esophagus: prognostic relevance of clinicopathological features and protein expression. Tumour Biol 2016;37:6691-9. [PMID: 26649862 DOI: 10.1007/s13277-015-4551-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
143 Jiang W, Mitra R, Lin CC, Wang Q, Cheng F, Zhao Z. Systematic dissection of dysregulated transcription factor-miRNA feed-forward loops across tumor types. Brief Bioinform 2016;17:996-1008. [PMID: 26655252 DOI: 10.1093/bib/bbv107] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
144 Xu D, Wang J, Zhou Z, He Z, Zhao Q. Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells. Mol Med Rep. 2015;12:7963-7970. [PMID: 26500101 DOI: 10.3892/mmr.2015.4477] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
145 Ferreira WA, Araújo MD, Anselmo NP, de Oliveira EH, Brito JR, Burbano RR, Harada ML, Borges Bdo N. Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors. PLoS One 2015;10:e0137259. [PMID: 26317630 DOI: 10.1371/journal.pone.0137259] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
146 Nault JC, Datta S, Imbeaud S, Franconi A, Mallet M, Couchy G, Letouzé E, Pilati C, Verret B, Blanc JF, Balabaud C, Calderaro J, Laurent A, Letexier M, Bioulac-Sage P, Calvo F, Zucman-Rossi J. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet 2015;47:1187-93. [PMID: 26301494 DOI: 10.1038/ng.3389] [Cited by in Crossref: 266] [Cited by in F6Publishing: 252] [Article Influence: 38.0] [Reference Citation Analysis]
147 Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol 2015;35 Suppl:S25-54. [PMID: 25892662 DOI: 10.1016/j.semcancer.2015.02.006] [Cited by in Crossref: 228] [Cited by in F6Publishing: 215] [Article Influence: 32.6] [Reference Citation Analysis]
148 Saini MK, Sanyal SN. Cell Cycle Regulation and Apoptotic Cell Death in Experimental Colon Carcinogenesis: Intervening with Cyclooxygenase-2 Inhibitors. Nutrition and Cancer 2015;67:620-36. [DOI: 10.1080/01635581.2015.1015743] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
149 Tulalamba W, Larbcharoensub N, Sirachainan E, Tantiwetrueangdet A, Janvilisri T. Transcriptome meta-analysis reveals dysregulated pathways in nasopharyngeal carcinoma. Tumour Biol 2015;36:5931-42. [PMID: 25724187 DOI: 10.1007/s13277-015-3268-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
150 Hou J, Zhao W, Huang ZN, Yang SM, Wang LJ, Jiang Y, Zhou ZS, Zheng MY, Jiang JL, Li SH, Li FN. Evaluation of Novel N-(piperidine-4-yl)benzamide Derivatives as Potential Cell Cycle Inhibitors in HepG2 Cells. Chem Biol Drug Des 2015;86:223-31. [PMID: 25430863 DOI: 10.1111/cbdd.12484] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
151 Liu H, Schmitz JC, Wei J, Cao S, Beumer JH, Strychor S, Cheng L, Liu M, Wang C, Wu N, Zhao X, Zhang Y, Liao J, Chu E, Lin X. Clove extract inhibits tumor growth and promotes cell cycle arrest and apoptosis. Oncol Res 2014;21:247-59. [PMID: 24854101 DOI: 10.3727/096504014X13946388748910] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 4.1] [Reference Citation Analysis]
152 Wu J, Lv Q, He J, Zhang H, Mei X, Cui K, Huang N, Xie W, Xu N, Zhang Y. MicroRNA-188 suppresses G1/S transition by targeting multiple cyclin/CDK complexes. Cell Commun Signal 2014;12:66. [PMID: 25304455 DOI: 10.1186/s12964-014-0066-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 32] [Article Influence: 1.1] [Reference Citation Analysis]
153 Vaish V, Rana C, Piplani H, Vaiphei K, Sanyal SN. Sulindac and Celecoxib regulate cell cycle progression by p53/p21 up regulation to induce apoptosis during initial stages of experimental colorectal cancer. Cell Biochem Biophys 2014;68:301-19. [PMID: 23857431 DOI: 10.1007/s12013-013-9711-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
154 Felipe KB, Kviecinski MR, da Silva FO, Bücker NF, Farias MS, Castro LSEPW, de Souza Grinevicius VMA, Motta NS, Correia JFG, Rossi MH, Pedrosa RC. Inhibition of tumor proliferation associated with cell cycle arrest caused by extract and fraction from Casearia sylvestris (Salicaceae). Journal of Ethnopharmacology 2014;155:1492-9. [DOI: 10.1016/j.jep.2014.07.040] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
155 Kim MS, Kim KH, Lee EH, Lee YM, Lee SH, Kim HD, Kim YZ. Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas. J Neurosurg. 2014;121:1189-1200. [PMID: 25148008 DOI: 10.3171/2014.7.jns132661] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
156 Bao ZS, Chen HM, Yang MY, Zhang CB, Yu K, Ye WL, Hu BQ, Yan W, Zhang W, Akers J, Ramakrishnan V, Li J, Carter B, Liu YW, Hu HM, Wang Z, Li MY, Yao K, Qiu XG, Kang CS, You YP, Fan XL, Song WS, Li RQ, Su XD, Chen CC, Jiang T. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome Res 2014;24:1765-73. [PMID: 25135958 DOI: 10.1101/gr.165126.113] [Cited by in Crossref: 186] [Cited by in F6Publishing: 185] [Article Influence: 23.3] [Reference Citation Analysis]
157 Choi YJ, Saez B, Anders L, Hydbring P, Stefano J, Bacon NA, Cook C, Kalaszczynska I, Signoretti S, Young RA, Scadden DT, Sicinski P. D-cyclins repress apoptosis in hematopoietic cells by controlling death receptor Fas and its ligand FasL. Dev Cell 2014;30:255-67. [PMID: 25087893 DOI: 10.1016/j.devcel.2014.06.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
158 Jarry M, Lecointre C, Malleval C, Desrues L, Schouft MT, Lejoncour V, Liger F, Lyvinec G, Joseph B, Loaëc N, Meijer L, Honnorat J, Gandolfo P, Castel H. Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis. Neuro Oncol 2014;16:1484-98. [PMID: 24891448 DOI: 10.1093/neuonc/nou102] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
159 Dimopoulos K, Gimsing P, Grønbæk K. The role of epigenetics in the biology of multiple myeloma. Blood Cancer J 2014;4:e207. [PMID: 24786391 DOI: 10.1038/bcj.2014.29] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 8.1] [Reference Citation Analysis]
160 Xu Q, Ma J, Lei J, Duan W, Sheng L, Chen X, Hu A, Wang Z, Wu Z, Wu E, Ma Q, Li X. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway. Biomed Res Int 2014;2014:546353. [PMID: 24812621 DOI: 10.1155/2014/546353] [Cited by in Crossref: 28] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
161 Bretones G, Delgado MD, León J. Myc and cell cycle control. Biochim Biophys Acta. 2015;1849:506-516. [PMID: 24704206 DOI: 10.1016/j.bbagrm.2014.03.013] [Cited by in Crossref: 294] [Cited by in F6Publishing: 308] [Article Influence: 36.8] [Reference Citation Analysis]
162 Wu J, Zhong D, Fu X, Liu Q, Kang L, Ding Z. Silencing of Ether à go-go 1 by shRNA inhibits osteosarcoma growth and cell cycle progression. Int J Mol Sci 2014;15:5570-81. [PMID: 24694542 DOI: 10.3390/ijms15045570] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
163 Reddy MV, Akula B, Cosenza SC, Athuluridivakar S, Mallireddigari MR, Pallela VR, Billa VK, Subbaiah DR, Bharathi EV, Vasquez-Del Carpio R, Padgaonkar A, Baker SJ, Reddy EP. Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5). J Med Chem 2014;57:578-99. [PMID: 24417566 DOI: 10.1021/jm401073p] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
164 Chang YJ, Hsu WH, Chang CH, Lan KL, Ting G, Lee TW. Combined therapeutic efficacy of 188Re-liposomes and sorafenib in an experimental colorectal cancer liver metastasis model by intrasplenic injection of C26-luc murine colon cancer cells. Mol Clin Oncol 2014;2:380-4. [PMID: 24772304 DOI: 10.3892/mco.2014.246] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
165 Gu H, Yang T, Fu S, Chen X, Guo L, Ni Y. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1. Biochem Biophys Res Commun. 2014;444:104-108. [PMID: 24440705 DOI: 10.1016/j.bbrc.2014.01.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
166 Zhang D, Wang S, Zhu L, Tian Y, Wang H, Zhuang Y, Li Y, Wang D. Profiling of hepatocellular carcinoma cell cycle regulating genes targeted by calycosin. Biomed Res Int 2013;2013:317926. [PMID: 24455688 DOI: 10.1155/2013/317926] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
167 Morrot A. The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host. Scientifica (Cairo) 2013;2013:965856. [PMID: 24455435 DOI: 10.1155/2013/965856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
168 Xu Y, Shi Y, Yuan Q, Liu X, Yan B, Chen L, Tao Y, Cao Y. Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells. J Exp Clin Cancer Res 2013;32:90. [PMID: 24499623 DOI: 10.1186/1756-9966-32-90] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
169 Kollmann K, Heller G, Schneckenleithner C, Warsch W, Scheicher R, Ott RG, Schäfer M, Fajmann S, Schlederer M, Schiefer AI, Reichart U, Mayerhofer M, Hoeller C, Zöchbauer-Müller S, Kerjaschki D, Bock C, Kenner L, Hoefler G, Freissmuth M, Green AR, Moriggl R, Busslinger M, Malumbres M, Sexl V. A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell 2013;24:167-81. [PMID: 23948297 DOI: 10.1016/j.ccr.2013.07.012] [Cited by in Crossref: 140] [Cited by in F6Publishing: 139] [Article Influence: 15.6] [Reference Citation Analysis]
170 Raemdonck K, Braeckmans K, Demeester J, De Smedt SC. Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery. Chem Soc Rev 2014;43:444-72. [PMID: 24100581 DOI: 10.1039/c3cs60299k] [Cited by in Crossref: 120] [Cited by in F6Publishing: 31] [Article Influence: 13.3] [Reference Citation Analysis]
171 Pawar S, Starosvetsky E, Orvis GD, Behringer RR, Bagchi IC, Bagchi MK. STAT3 regulates uterine epithelial remodeling and epithelial-stromal crosstalk during implantation. Mol Endocrinol 2013;27:1996-2012. [PMID: 24100212 DOI: 10.1210/me.2013-1206] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 7.0] [Reference Citation Analysis]
172 Xiao F, Zhang W, Chen L, Chen F, Xie H, Xing C, Yu X, Ding S, Chen K, Guo H. MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma. J Transl Med. 2013;11:195. [PMID: 23967867 DOI: 10.1186/1479-5876-11-195] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
173 Li Q, Kawamura K, Yang S, Okamoto S, Kobayashi H, Tada Y, Sekine I, Takiguchi Y, Shingyouji M, Tatsumi K, Shimada H, Hiroshima K, Tagawa M. Interferon-β produces synergistic combinatory anti-tumor effects with cisplatin or pemetrexed on mesothelioma cells. PLoS One 2013;8:e72709. [PMID: 23977343 DOI: 10.1371/journal.pone.0072709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
174 Schemmer J, Araúzo-Bravo MJ, Haas N, Schäfer S, Weber SN, Becker A, Eckert D, Zimmer A, Nettersheim D, Schorle H. Transcription factor TFAP2C regulates major programs required for murine fetal germ cell maintenance and haploinsufficiency predisposes to teratomas in male mice. PLoS One. 2013;8:e71113. [PMID: 23967156 DOI: 10.1371/journal.pone.0071113] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
175 Heath JL, Weiss JM, Lavau CP, Wechsler DS. Iron deprivation in cancer--potential therapeutic implications. Nutrients 2013;5:2836-59. [PMID: 23887041 DOI: 10.3390/nu5082836] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 8.3] [Reference Citation Analysis]
176 Koo KH, Kim H, Bae YK, Kim K, Park BK, Lee CH, Kim YN. Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2. Cell Death Dis. 2013;4:e693. [PMID: 23807222 DOI: 10.1038/cddis.2013.223] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
177 Chumduri C, Gurumurthy R, Zadora P, Mi Y, Meyer T. Chlamydia Infection Promotes Host DNA Damage and Proliferation but Impairs the DNA Damage Response. Cell Host & Microbe 2013;13:746-58. [DOI: 10.1016/j.chom.2013.05.010] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 11.0] [Reference Citation Analysis]
178 Otjacques E, Binsfeld M, Rocks N, Blacher S, Vanderkerken K, Noel A, Beguin Y, Cataldo D, Caers J. Mithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factors. PLoS One 2013;8:e62818. [PMID: 23667526 DOI: 10.1371/journal.pone.0062818] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
179 Baker SJ, Reddy EP. CDK4: A Key Player in the Cell Cycle, Development, and Cancer. Genes Cancer 2012;3:658-69. [PMID: 23634254 DOI: 10.1177/1947601913478972] [Cited by in Crossref: 95] [Cited by in F6Publishing: 88] [Article Influence: 10.6] [Reference Citation Analysis]
180 Li R, Hayward SD. Potential of protein kinase inhibitors for treating herpesvirus-associated disease. Trends Microbiol 2013;21:286-95. [PMID: 23608036 DOI: 10.1016/j.tim.2013.03.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
181 Huang S, Zhu Z, Wang Y, Wang Y, Xu L, Chen X, Xu Q, Zhang Q, Zhao X, Yu Y, Wu D. Tet1 is required for Rb phosphorylation during G1/S phase transition. Biochem Biophys Res Commun 2013;434:241-4. [PMID: 23542465 DOI: 10.1016/j.bbrc.2013.02.110] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
182 Goto H, Inoko A, Inagaki M. Cell cycle progression by the repression of primary cilia formation in proliferating cells. Cell Mol Life Sci 2013;70:3893-905. [PMID: 23475109 DOI: 10.1007/s00018-013-1302-8] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 9.6] [Reference Citation Analysis]
183 Choi YJ, Li X, Hydbring P, Sanda T, Stefano J, Christie AL, Signoretti S, Look AT, Kung AL, von Boehmer H, Sicinski P. The requirement for cyclin D function in tumor maintenance. Cancer Cell 2012;22:438-51. [PMID: 23079655 DOI: 10.1016/j.ccr.2012.09.015] [Cited by in Crossref: 208] [Cited by in F6Publishing: 192] [Article Influence: 23.1] [Reference Citation Analysis]
184 Lu X, Wu L, Liu Z, Xie L, Wang S. Peripheral blood mononuclear cells inhibit proliferation and promote apoptosis of HeLa cells following stimulation with Bacillus Calmette-Guerin. Exp Ther Med 2013;5:561-6. [PMID: 23404059 DOI: 10.3892/etm.2012.855] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
185 Chakravarti B, Maurya R, Siddiqui JA, Bid HK, Rajendran SM, Yadav PP, Konwar R. In vitro anti-breast cancer activity of ethanolic extract of Wrightia tomentosa: role of pro-apoptotic effects of oleanolic acid and urosolic acid. J Ethnopharmacol 2012;142:72-9. [PMID: 22855944 DOI: 10.1016/j.jep.2012.04.015] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 9.0] [Reference Citation Analysis]
186 Knudsen KE. Cyclin D1 goes metabolic: dual functions of cyclin D1 in regulating lipogenesis. Cell Cycle 2012;11:3533-4. [PMID: 22951541 DOI: 10.4161/cc.22039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
187 Canavese M, Santo L, Raje N. Cyclin dependent kinases in cancer: potential for therapeutic intervention. Cancer Biol Ther. 2012;13:451-457. [PMID: 22361734 DOI: 10.4161/cbt.19589] [Cited by in Crossref: 95] [Cited by in F6Publishing: 83] [Article Influence: 9.5] [Reference Citation Analysis]
188 Heaney JD, Anderson EL, Michelson MV, Zechel JL, Conrad PA, Page DC, Nadeau JH. Germ cell pluripotency, premature differentiation and susceptibility to testicular teratomas in mice. Development 2012;139:1577-86. [PMID: 22438569 DOI: 10.1242/dev.076851] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
189 Marx SJ. Hyperparathyroid genes: sequences reveal answers and questions. Endocr Pract 2011;17 Suppl 3:18-27. [PMID: 21454225 DOI: 10.4158/EP11067.RA] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
190 Wang H, Kumar TR. Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis. Gene Expr Patterns 2012;12:136-44. [PMID: 22289519 DOI: 10.1016/j.gep.2012.01.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
191 Zhao X, Mirza S, Alshareeda A, Zhang Y, Gurumurthy CB, Bele A, Kim JH, Mohibi S, Goswami M, Lele SM, West W, Qiu F, Ellis IO, Rakha EA, Green AR, Band H, Band V. Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. Breast Cancer Res Treat 2012;134:171-80. [PMID: 22270930 DOI: 10.1007/s10549-011-1946-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
192 Antico Arciuch VG, Elguero ME, Poderoso JJ, Carreras MC. Mitochondrial regulation of cell cycle and proliferation. Antioxid Redox Signal. 2012;16:1150-1180. [PMID: 21967640 DOI: 10.1089/ars.2011.4085] [Cited by in Crossref: 260] [Cited by in F6Publishing: 224] [Article Influence: 26.0] [Reference Citation Analysis]
193 Willis RE. Human gene control by vital oncogenes: revisiting a theoretical model and its implications for targeted cancer therapy. Int J Mol Sci 2012;13:316-35. [PMID: 22312254 DOI: 10.3390/ijms13010316] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
194 Kim JH, Gupta SC, Park B, Yadav VR, Aggarwal BB. Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Mol Nutr Food Res 2012;56:454-65. [PMID: 22147524 DOI: 10.1002/mnfr.201100270] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 6.6] [Reference Citation Analysis]
195 Ray D, Terao Y, Christov K, Kaldis P, Kiyokawa H. Cdk2-null mice are resistant to ErbB-2-induced mammary tumorigenesis. Neoplasia 2011;13:439-44. [PMID: 21532884 DOI: 10.1593/neo.101704] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
196 Breheny D, Oke O, Faux SP. The Use of In Vitro Systems to Assess Cancer Mechanisms and the Carcinogenic Potential of Chemicals. Altern Lab Anim 2011;39:233-55. [DOI: 10.1177/026119291103900301] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
197 Jirawatnotai S, Hu Y, Michowski W, Elias JE, Becks L, Bienvenu F, Zagozdzon A, Goswami T, Wang YE, Clark AB. A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature. 2011;474:230-234. [PMID: 21654808 DOI: 10.1038/nature10155] [Cited by in Crossref: 220] [Cited by in F6Publishing: 213] [Article Influence: 20.0] [Reference Citation Analysis]
198 Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674. [PMID: 21376230 DOI: 10.1016/j.cell.2011.02.013] [Cited by in Crossref: 33789] [Cited by in F6Publishing: 31247] [Article Influence: 3071.7] [Reference Citation Analysis]
199 Cuomo ME, Platt GM, Pearl LH, Mittnacht S. Cyclin-cyclin-dependent kinase regulatory response is linked to substrate recognition. J Biol Chem 2011;286:9713-25. [PMID: 21233209 DOI: 10.1074/jbc.M110.173872] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
200 Grosse-gehling P, Wuest F, Peppel T, Köckerling M, Mamat C. 1-(3-[ 18 F]fluoropropyl)piperazines as model compounds for the radiofluorination of pyrido[2,3- d ]pyrimidines. Radiochimica Acta 2011;99:365-73. [DOI: 10.1524/ract.2011.1834] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
201 Davidson B. The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma: Characteristics of malignant mesothelioma and serous carcinoma. Cytopathology 2011;22:5-21. [DOI: 10.1111/j.1365-2303.2010.00829.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
202 Kowalewski AA, Randall RL, Lessnick SL. Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis. Sarcoma 2011;2011:598704. [PMID: 21052502 DOI: 10.1155/2011/598704] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
203 Cho YS, Borland M, Brain C, Chen CH, Cheng H, Chopra R, Chung K, Groarke J, He G, Hou Y, Kim S, Kovats S, Lu Y, O’reilly M, Shen J, Smith T, Trakshel G, Vögtle M, Xu M, Xu M, Sung MJ. 4-(Pyrazol-4-yl)-pyrimidines as Selective Inhibitors of Cyclin-Dependent Kinase 4/6. J Med Chem 2010;53:7938-57. [DOI: 10.1021/jm100571n] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 4.7] [Reference Citation Analysis]
204 Wu Q, Qin SK, Teng FM, Chen CJ, Wang R. Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells. J Hematol Oncol. 2010;3:43. [PMID: 21034513 DOI: 10.1186/1756-8722-3-43] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
205 Séïté J, Cornec D, Renaudineau Y, Youinou P, Mageed RA, Hillion S. IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes. Blood 2010;116:1698-704. [DOI: 10.1182/blood-2009-12-261461] [Cited by in Crossref: 109] [Cited by in F6Publishing: 104] [Article Influence: 9.1] [Reference Citation Analysis]
206 Balakrishnan A, Stearns AT, Park PJ, Dreyfuss JM, Ashley SW, Rhoads DB, Tavakkolizadeh A. MicroRNA mir-16 is anti-proliferative in enterocytes and exhibits diurnal rhythmicity in intestinal crypts. Exp Cell Res 2010;316:3512-21. [PMID: 20633552 DOI: 10.1016/j.yexcr.2010.07.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
207 Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010;10:550-60. [DOI: 10.1038/nrc2886] [Cited by in Crossref: 944] [Cited by in F6Publishing: 873] [Article Influence: 78.7] [Reference Citation Analysis]
208 Sarita Rajender P, Ramasree D, Bhargavi K, Vasavi M, Uma V. Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer—a review. Journal of Receptors and Signal Transduction 2010;30:206-13. [DOI: 10.3109/10799893.2010.488649] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
209 Morris LG, Veeriah S, Chan TA. Genetic determinants at the interface of cancer and neurodegenerative disease. Oncogene 2010;29:3453-64. [PMID: 20418918 DOI: 10.1038/onc.2010.127] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 5.7] [Reference Citation Analysis]
210 Mateen S, Tyagi A, Agarwal C, Singh RP, Agarwal R. Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators. Mol Carcinog. 2010;49:247-258. [PMID: 19908243 DOI: 10.1002/mc.20595] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
211 Santo L, Vallet S, Hideshima T, Cirstea D, Ikeda H, Pozzi S, Patel K, Okawa Y, Gorgun G, Perrone G, Calabrese E, Yule M, Squires M, Ladetto M, Boccadoro M, Richardson PG, Munshi NC, Anderson KC, Raje N. AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition. Oncogene 2010;29:2325-36. [PMID: 20101221 DOI: 10.1038/onc.2009.510] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 6.7] [Reference Citation Analysis]
212 Jeon S, Choi J, Lee K, Park SK, Yoo K, Noh D, Ahn S, Kang D. Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer. Breast Cancer Res Treat 2010;121:737-42. [DOI: 10.1007/s10549-009-0640-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
213 Avigad S, Shukla S, Naumov I, Cohen IJ, Ash S, Meller I, Kollender Y, Issakov J, Yaniv I. Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma. Pediatr Blood Cancer 2009;53:1023-8. [PMID: 19637319 DOI: 10.1002/pbc.22115] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
214 Corsino P, Horenstein N, Ostrov D, Rowe T, Law M, Barrett A, Aslanidi G, Cress WD, Law B. A novel class of cyclin-dependent kinase inhibitors identified by molecular docking act through a unique mechanism. J Biol Chem 2009;284:29945-55. [PMID: 19710018 DOI: 10.1074/jbc.M109.055251] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
215 Sandoval R, Pilkinton M, Colamonici OR. Deletion of the p107/p130-binding domain of Mip130/LIN-9 bypasses the requirement for CDK4 activity for the dissociation of Mip130/LIN-9 from p107/p130-E2F4 complex. Exp Cell Res 2009;315:2914-20. [PMID: 19619530 DOI: 10.1016/j.yexcr.2009.07.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
216 Lerner M, Harada M, Lovén J, Castro J, Davis Z, Oscier D, Henriksson M, Sangfelt O, Grandér D, Corcoran MM. DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1. Exp Cell Res. 2009;315:2941-2952. [PMID: 19591824 DOI: 10.1016/j.yexcr.2009.07.001] [Cited by in Crossref: 114] [Cited by in F6Publishing: 109] [Article Influence: 8.8] [Reference Citation Analysis]
217 Wang Y, Rathinam R, Walch A, Alahari SK. ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation. J Biol Chem 2009;284:23094-106. [PMID: 19546220 DOI: 10.1074/jbc.M109.012617] [Cited by in Crossref: 73] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
218 Graf F, Koehler L, Kniess T, Wuest F, Mosch B, Pietzsch J. [Not Available]. J Oncol 2009;2009:106378. [PMID: 19551155 DOI: 10.1155/2009/106378] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
219 Rojas P, Benavides F, Blando J, Perez C, Cardenas K, Richie E, Knudsen ES, Johnson DG, Senderowicz AM, Rodriguez-Puebla ML, Conti CJ. Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b). Mol Carcinog 2009;48:508-16. [PMID: 18942117 DOI: 10.1002/mc.20489] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
220 Inaba H, Kuboniwa M, Bainbridge B, Yilmaz O, Katz J, Shiverick KT, Amano A, Lamont RJ. Porphyromonas gingivalis invades human trophoblasts and inhibits proliferation by inducing G1 arrest and apoptosis. Cell Microbiol 2009;11:1517-32. [PMID: 19523155 DOI: 10.1111/j.1462-5822.2009.01344.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
221 Wang Y, Blelloch R. Cell cycle regulation by MicroRNAs in embryonic stem cells. Cancer Res 2009;69:4093-6. [PMID: 19435891 DOI: 10.1158/0008-5472.CAN-09-0309] [Cited by in Crossref: 83] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
222 Di Fiore R, Santulli A, Ferrante RD, Giuliano M, De Blasio A, Messina C, Pirozzi G, Tirino V, Tesoriere G, Vento R. Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. J Cell Physiol 2009;219:301-13. [PMID: 19160414 DOI: 10.1002/jcp.21667] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 5.0] [Reference Citation Analysis]
223 Davidson B. New diagnostic and molecular characteristics of malignant mesothelioma. Ultrastruct Pathol 2008;32:227-40. [PMID: 19117264 DOI: 10.1080/01913120802454298] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
224 Siqueira JM, Gazola AC, Farias MR, Volkov L, Rivard N, de Brum-fernandes AJ, Ribeiro-do-valle RM. Evaluation of the antitumoral effect of dihydrocucurbitacin-B in both in vitro and in vivo models. Cancer Chemother Pharmacol 2009;64:529-38. [DOI: 10.1007/s00280-008-0901-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
225 Kumar AR, Li Q, Hudson WA, Chen W, Sam T, Yao Q, Lund EA, Wu B, Kowal BJ, Kersey JH. A role for MEIS1 in MLL-fusion gene leukemia. Blood 2009;113:1756-8. [PMID: 19109563 DOI: 10.1182/blood-2008-06-163287] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 4.6] [Reference Citation Analysis]
226 Staropoli JF. Tumorigenesis and neurodegeneration: two sides of the same coin? Bioessays 2008;30:719-27. [DOI: 10.1002/bies.20784] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
227 González I, Aparicio R, Busturia A. Functional characterization of the dRYBP gene in Drosophila. Genetics 2008;179:1373-88. [PMID: 18562658 DOI: 10.1534/genetics.107.082966] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
228 Lee SH, Cekanova M, Baek SJ. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog 2008;47:197-208. [PMID: 18058799 DOI: 10.1002/mc.20374] [Cited by in Crossref: 127] [Cited by in F6Publishing: 110] [Article Influence: 9.1] [Reference Citation Analysis]
229 El-Dahr SS, Aboudehen K, Saifudeen Z. Transcriptional control of terminal nephron differentiation. Am J Physiol Renal Physiol 2008;294:F1273-8. [PMID: 18287399 DOI: 10.1152/ajprenal.00562.2007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
230 Al-khalaf HH, Lach B, Allam A, Hassounah M, Alkhani A, Elkum N, Alrokayan SA, Aboussekhra A. Expression of survivin and p16INK4a/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells. Brain Research 2008;1188:25-34. [DOI: 10.1016/j.brainres.2007.10.074] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
231 Ciccarelli M, Santulli G, Campanile A, Galasso G, Cervèro P, Altobelli GG, Cimini V, Pastore L, Piscione F, Trimarco B, Iaccarino G. Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. Br J Pharmacol 2008;153:936-46. [PMID: 18084315 DOI: 10.1038/sj.bjp.0707637] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
232 Guo H, Cun W, Liu L, Wang L, Zhao H, Dong C, Li Q. Immediate-early gene product ICP22 inhibits the trans-transcription activating function of P53-mdm-2. Sci China C Life Sci 2007;50:473-8. [PMID: 17653667 DOI: 10.1007/s11427-007-0039-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
233 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
234 Kuboniwa M, Hasegawa Y, Mao S, Shizukuishi S, Amano A, Lamont RJ, Yilmaz O. P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes Infect 2008;10:122-8. [PMID: 18280195 DOI: 10.1016/j.micinf.2007.10.011] [Cited by in Crossref: 102] [Cited by in F6Publishing: 104] [Article Influence: 6.8] [Reference Citation Analysis]
235 Davidson B, Skrede M, Silins I, Shih IeM, Trope CG, Flørenes VA. Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma. Cancer 2007;110:1264-71. [PMID: 17647260 DOI: 10.1002/cncr.22918] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
236 Lu Q, Jourd'Heuil FL, Jourd'Heuil D. Redox control of G(1)/S cell cycle regulators during nitric oxide-mediated cell cycle arrest. J Cell Physiol 2007;212:827-39. [PMID: 17443686 DOI: 10.1002/jcp.21079] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
237 Ji P, Bäumer N, Yin T, Diederichs S, Zhang F, Beger C, Welte K, Fulda S, Berdel WE, Serve H, Müller-Tidow C. DNA damage response involves modulation of Ku70 and Rb functions by cyclin A1 in leukemia cells. Int J Cancer 2007;121:706-13. [PMID: 17455244 DOI: 10.1002/ijc.22634] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
238 Pitari GM, Li P, Lin JE, Zuzga D, Gibbons AV, Snook AE, Schulz S, Waldman SA. The paracrine hormone hypothesis of colorectal cancer. Clin Pharmacol Ther. 2007;82:441-447. [PMID: 17687268 DOI: 10.1038/sj.clpt.6100325] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
239 Rao JS, Bhoopathi P, Chetty C, Gujrati M, Lakka SS. MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16(INK4a) and mitogen-activated protein kinase pathway. Cancer Res. 2007;67:4956-4964. [PMID: 17510426 DOI: 10.1158/0008-5472.CAN-07-0380] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
240 Lévêque C, Marsaud V, Renoir J, Sola B. Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytes. Experimental Cell Research 2007;313:2719-29. [DOI: 10.1016/j.yexcr.2007.04.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
241 Fang J, Menon M, Kapelle W, Bogacheva O, Bogachev O, Houde E, Browne S, Sathyanarayana P, Wojchowski DM. EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts. Blood 2007;110:2361-70. [PMID: 17548578 DOI: 10.1182/blood-2006-12-063503] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
242 Kida A, Kakihana K, Kotani S, Kurosu T, Miura O. Glycogen synthase kinase-3beta and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells. Oncogene 2007;26:6630-40. [PMID: 17486076 DOI: 10.1038/sj.onc.1210490] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
243 Seabra L, Warenius H. Proteomic co-expression of cyclin-dependent kinases 1 and 4 in human cancer cells. European Journal of Cancer 2007;43:1483-92. [DOI: 10.1016/j.ejca.2007.03.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
244 Lu LH, Ran ZH. Effects of oxymatrine on the expression of P21, P27, Cyclin E1 and CDK2 in human colon cancer cell line SW1116. Shijie Huaren Xiaohua Zazhi 2007; 15(12): 1353-1357 [DOI: 10.11569/wcjd.v15.i12.1353] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
245 Escudero LM, Freeman M. Mechanism of G1 arrest in the Drosophila eye imaginal disc. BMC Dev Biol 2007;7:13. [PMID: 17335573 DOI: 10.1186/1471-213X-7-13] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
246 Salim K, Guest PC, Skynner HA, Bilsland JG, Bonnert TP, Mcallister G, Munoz-sanjuan I. Identification of Proteomic Changes during Differentiation of Adult Mouse Subventricular Zone Progenitor Cells. Stem Cells and Development 2007;16:143-66. [DOI: 10.1089/scd.2006.00100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
247 Chen S, Chen L, Le NT, Zhao C, Sidduri A, Lou JP, Michoud C, Portland L, Jackson N, Liu JJ, Konzelmann F, Chi F, Tovar C, Xiang Q, Chen Y, Wen Y, Vassilev LT. Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors. Bioorg Med Chem Lett 2007;17:2134-8. [PMID: 17303421 DOI: 10.1016/j.bmcl.2007.01.081] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
248 Martínez-Diez M, Santamaría G, Ortega AD, Cuezva JM. Biogenesis and dynamics of mitochondria during the cell cycle: significance of 3'UTRs. PLoS One 2006;1:e107. [PMID: 17205111 DOI: 10.1371/journal.pone.0000107] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 4.9] [Reference Citation Analysis]
249 Chattopadhyay S, Tracy E, Liang P, Robledo O, Rose-John S, Baumann H. Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells. J Biol Chem 2007;282:3014-26. [PMID: 17148439 DOI: 10.1074/jbc.M609655200] [Cited by in Crossref: 75] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
250 Chu XJ, DePinto W, Bartkovitz D, So SS, Vu BT, Packman K, Lukacs C, Ding Q, Jiang N, Wang K, Goelzer P, Yin X, Smith MA, Higgins BX, Chen Y, Xiang Q, Moliterni J, Kaplan G, Graves B, Lovey A, Fotouhi N. Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity. J Med Chem 2006;49:6549-60. [PMID: 17064073 DOI: 10.1021/jm0606138] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 4.8] [Reference Citation Analysis]
251 Sarfaraz S, Afaq F, Adhami VM, Malik A, Mukhtar H. Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle Arrest. Journal of Biological Chemistry 2006;281:39480-91. [DOI: 10.1074/jbc.m603495200] [Cited by in Crossref: 121] [Cited by in F6Publishing: 62] [Article Influence: 7.6] [Reference Citation Analysis]
252 Bockstaele L, Coulonval K, Kooken H, Paternot S, Roger PP. Regulation of CDK4. Cell Div 2006;1:25. [PMID: 17092340 DOI: 10.1186/1747-1028-1-25] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
253 Héron-Milhavet L, Franckhauser C, Rana V, Berthenet C, Fisher D, Hemmings BA, Fernandez A, Lamb NJ. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Mol Cell Biol 2006;26:8267-80. [PMID: 16982699 DOI: 10.1128/MCB.00201-06] [Cited by in Crossref: 124] [Cited by in F6Publishing: 76] [Article Influence: 7.8] [Reference Citation Analysis]
254 Clappier E, Cuccuini W, Cayuela JM, Vecchione D, Baruchel A, Dombret H, Sigaux F, Soulier J. Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias. Leukemia 2006;20:82-6. [PMID: 16270038 DOI: 10.1038/sj.leu.2404008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
255 Knudsen ES, Knudsen KE. Retinoblastoma tumor suppressor: where cancer meets the cell cycle. Exp Biol Med (Maywood) 2006;231:1271-81. [PMID: 16816134 DOI: 10.1177/153537020623100713] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 3.9] [Reference Citation Analysis]
256 Wikman H, Kettunen E. Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer. Expert Rev Anticancer Ther 2006;6:515-30. [PMID: 16613540 DOI: 10.1586/14737140.6.4.515] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
257 Gao N, Kramer L, Rahmani M, Dent P, Grant S. The Three-Substituted Indolinone Cyclin-Dependent Kinase 2 Inhibitor 3-[1-(3 H -Imidazol-4-yl)-meth-( Z )-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) Kills Human Leukemia Cells via Down-Regulation of Mcl-1 through a Transcriptional Mechanism. Mol Pharmacol 2006;70:645-55. [DOI: 10.1124/mol.106.024505] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
258 Sandoval R, Xue J, Tian X, Barrett K, Pilkinton M, Ucker DS, Raychaudhuri P, Kineman RD, Luque RM, Baida G, Zou X, Valli VE, Cook JL, Kiyokawa H, Colamonici OR. A mutant allele of BARA/LIN-9 rescues the cdk4-/- phenotype by releasing the repression on E2F-regulated genes. Exp Cell Res 2006;312:2465-75. [PMID: 16730350 DOI: 10.1016/j.yexcr.2006.04.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
259 Suizu F, Ryo A, Wulf G, Lim J, Lu KP. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis. Mol Cell Biol 2006;26:1463-79. [PMID: 16449657 DOI: 10.1128/MCB.26.4.1463-1479.2006] [Cited by in Crossref: 76] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
260 Habuchi T. Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model. Future Oncology 2006;2:233-45. [DOI: 10.2217/14796694.2.2.233] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
261 Shuai XM, Han GX, Wang GB, Chen JH. Cyclin D1 antisense oligodexoyneucleotides inhibits growth and enhances chemosensitivity in gastric carcinoma cells. World J Gastroenterol 2006; 12(11): 1766-1769 [PMID: 16586549 DOI: 10.3748/wjg.v12.i11.1766] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
262 Pietsch EC, Humbey O, Murphy ME. Polymorphisms in the p53 pathway. Oncogene 2006;25:1602-11. [DOI: 10.1038/sj.onc.1209367] [Cited by in Crossref: 151] [Cited by in F6Publishing: 135] [Article Influence: 9.4] [Reference Citation Analysis]
263 Zhang J, Del Aguila R, Schneider C, Schneider BL. The importance of being big. J Investig Dermatol Symp Proc 2005;10:131-41. [PMID: 16358818 DOI: 10.1111/j.1087-0024.2005.200414.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
264 Ciccarelli C, Marampon F, Scoglio A, Mauro A, Giacinti C, De Cesaris P, Zani BM. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells. Mol Cancer 2005;4:41. [PMID: 16351709 DOI: 10.1186/1476-4598-4-41] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
265 Budhu AS, Wang XW. Loading and unloading: orchestrating centrosome duplication and spindle assembly by Ran/Crm1. Cell Cycle 2005;4:1510-4. [PMID: 16294017 DOI: 10.4161/cc.4.11.2187] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
266 Holm TM, Jackson-Grusby L, Brambrink T, Yamada Y, Rideout WM 3rd, Jaenisch R. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 2005;8:275-85. [PMID: 16226703 DOI: 10.1016/j.ccr.2005.09.007] [Cited by in Crossref: 171] [Cited by in F6Publishing: 160] [Article Influence: 10.1] [Reference Citation Analysis]
267 Iaccarino G, Ciccarelli M, Sorriento D, Galasso G, Campanile A, Santulli G, Cipolletta E, Cerullo V, Cimini V, Altobelli GG, Piscione F, Priante O, Pastore L, Chiariello M, Salvatore F, Koch WJ, Trimarco B. Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 2005;97:1182-9. [PMID: 16239589 DOI: 10.1161/01.RES.0000191541.06788.bb] [Cited by in Crossref: 107] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
268 Zhang K, Dent SY. Histone modifying enzymes and cancer: Going beyond histones. J Cell Biochem 2005;96:1137-48. [DOI: 10.1002/jcb.20615] [Cited by in Crossref: 107] [Cited by in F6Publishing: 99] [Article Influence: 6.3] [Reference Citation Analysis]
269 Kuroki T, Jimbow K. Preface. Journal of Investigative Dermatology Symposium Proceedings 1999;4:v-vi. [DOI: 10.1038/sj.jidsp.5640191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]